-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Industry News] Recently, the Office of the Joint Conference on Centralized Purchasing of Medicines and Medical Consumables in Jiangxi Province issued the "Notice on the Implementation of the Results of the Selection of the Procurement of Medicines in the Four Provinces Alliance of Gansu, Guangdong, Henan and Hubei" (hereinafter referred to as the "Notice")
.
According to the notification, there are 7 varieties selected, and the implementation time of the selected results will start from 0:00 on May 20, 2022
.
It is reported that the selected 7 varieties include piperacillin sodium for injection, cefathiamidine for injection, cefotaxime sodium for injection, ceftizoxime sodium for injection, somatostatin for injection, propofol emulsion injection, sodium hydrochloride Meifen injection, the companies involved include Suzhou Erye Pharmaceutical Co.
, Ltd.
, Shandong Vibration Taisheng Pharmaceutical Co.
, Ltd.
, Shandong Luoxin Pharmaceutical Group Co.
, Ltd.
, Guangdong Jincheng Jinsu Pharmaceutical Co.
, Ltd.
, Shanghai Huayuan Pharmaceutical (Ningxia) Sha Sai Pharmaceutical Co.
, Ltd.
, Beijing Fresenius Kabi Pharmaceutical Co.
, Ltd.
, Sichuan Guorui Pharmaceutical Co.
, Ltd.
and other multi-pharmaceutical enterprises
.
Among them, Shandong Luoxin Pharmaceutical won the bid for cefathiamidine for injection and ceftizoxime sodium for injection
.
The data shows that in 2021, Shandong Luoxin Pharmaceutical's sales of cefathiamidine for injection for injection will be 14.
7403 million yuan, accounting for 0.
23% of the main business income in 2021; the sales of ceftizoxime sodium for injection will be 108.
8508 million yuan , accounting for 1.
71% of the main business revenue in 2021
.
Shandong Luoxin Pharmaceutical stated that the implementation of this centralized procurement requires medical institutions in the alliance regions to give priority to the selected drugs in this centralized procurement of drugs during the procurement cycle, and to ensure the completion of the agreed procurement volume
.
After the company signs and implements the procurement contract in the future, it will help to expand the sales of the selected products in the four provinces of Gansu, Guangdong, Henan and Hubei, increase the market share of the selected products, enhance the company's brand influence, and have a positive impact on the company's future business performance.
influence
.
It is understood that the procurement of drugs in the four provinces of Jiangxi, Guangdong, Henan and Hubei will start from the end of September 2021.
The four provinces participating in the alliance are Jiangxi, Guangdong, Henan, and Hubei.
The office of the Jiangxi Provincial Joint Conference on Centralized Purchasing of Pharmaceuticals and Medical Consumables will undertake the daily work.
and specific implementation
.
The procurement cycle is as follows: if one company is selected, the procurement cycle is 1 year; if two companies are selected, the procurement cycle is 2 years
.
The first-year procurement cycle is from May 20, 2022 to May 19, 2023
.
The purchase and sale agreement is signed once a year during the purchase cycle
.
When renewing the purchase and sale agreement, in principle, the agreed purchase volume shall not be less than the agreed purchase volume of the selected product in the previous year
.
During the procurement cycle, when the results of the centralized drug procurement organized by the state and the selected results of this centralized drug procurement overlap, if the selected companies are different, the results of the alliance region selection can be executed in the first year, and the national selected results will be executed when the contract is renewed in the second year.
The winning result; if the winning company is the same but the price is different, the winning result with the lower price will be executed
.
According to the industry, with the gradual normalization of volume procurement, the forms of centralized procurement are also becoming more and more abundant
.
From the current point of view, the pace of centralized procurement across the country is progressing steadily
.
It is reported that the National Medical Insurance Bureau has made it clear that by the end of 2022, each province (including the inter-provincial alliance) will carry out its own centralized procurement of no less than 100 varieties of drugs, and must include chemical drugs, Chinese patent medicines, orthopedic trauma, oral cavity Implants, drug balloons and other consumables
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
According to the notification, there are 7 varieties selected, and the implementation time of the selected results will start from 0:00 on May 20, 2022
.
It is reported that the selected 7 varieties include piperacillin sodium for injection, cefathiamidine for injection, cefotaxime sodium for injection, ceftizoxime sodium for injection, somatostatin for injection, propofol emulsion injection, sodium hydrochloride Meifen injection, the companies involved include Suzhou Erye Pharmaceutical Co.
, Ltd.
, Shandong Vibration Taisheng Pharmaceutical Co.
, Ltd.
, Shandong Luoxin Pharmaceutical Group Co.
, Ltd.
, Guangdong Jincheng Jinsu Pharmaceutical Co.
, Ltd.
, Shanghai Huayuan Pharmaceutical (Ningxia) Sha Sai Pharmaceutical Co.
, Ltd.
, Beijing Fresenius Kabi Pharmaceutical Co.
, Ltd.
, Sichuan Guorui Pharmaceutical Co.
, Ltd.
and other multi-pharmaceutical enterprises
.
Among them, Shandong Luoxin Pharmaceutical won the bid for cefathiamidine for injection and ceftizoxime sodium for injection
.
The data shows that in 2021, Shandong Luoxin Pharmaceutical's sales of cefathiamidine for injection for injection will be 14.
7403 million yuan, accounting for 0.
23% of the main business income in 2021; the sales of ceftizoxime sodium for injection will be 108.
8508 million yuan , accounting for 1.
71% of the main business revenue in 2021
.
Shandong Luoxin Pharmaceutical stated that the implementation of this centralized procurement requires medical institutions in the alliance regions to give priority to the selected drugs in this centralized procurement of drugs during the procurement cycle, and to ensure the completion of the agreed procurement volume
.
After the company signs and implements the procurement contract in the future, it will help to expand the sales of the selected products in the four provinces of Gansu, Guangdong, Henan and Hubei, increase the market share of the selected products, enhance the company's brand influence, and have a positive impact on the company's future business performance.
influence
.
It is understood that the procurement of drugs in the four provinces of Jiangxi, Guangdong, Henan and Hubei will start from the end of September 2021.
The four provinces participating in the alliance are Jiangxi, Guangdong, Henan, and Hubei.
The office of the Jiangxi Provincial Joint Conference on Centralized Purchasing of Pharmaceuticals and Medical Consumables will undertake the daily work.
and specific implementation
.
The procurement cycle is as follows: if one company is selected, the procurement cycle is 1 year; if two companies are selected, the procurement cycle is 2 years
.
The first-year procurement cycle is from May 20, 2022 to May 19, 2023
.
The purchase and sale agreement is signed once a year during the purchase cycle
.
When renewing the purchase and sale agreement, in principle, the agreed purchase volume shall not be less than the agreed purchase volume of the selected product in the previous year
.
During the procurement cycle, when the results of the centralized drug procurement organized by the state and the selected results of this centralized drug procurement overlap, if the selected companies are different, the results of the alliance region selection can be executed in the first year, and the national selected results will be executed when the contract is renewed in the second year.
The winning result; if the winning company is the same but the price is different, the winning result with the lower price will be executed
.
According to the industry, with the gradual normalization of volume procurement, the forms of centralized procurement are also becoming more and more abundant
.
From the current point of view, the pace of centralized procurement across the country is progressing steadily
.
It is reported that the National Medical Insurance Bureau has made it clear that by the end of 2022, each province (including the inter-provincial alliance) will carry out its own centralized procurement of no less than 100 varieties of drugs, and must include chemical drugs, Chinese patent medicines, orthopedic trauma, oral cavity Implants, drug balloons and other consumables
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
